Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Recombinant COVID variants: What is Omicron XE?

When large volumes of two viruses that are genetically linked circulate, there’s a risk of a new ‘hybrid’ virus forming.

Al Jazeera

Mid-Afternoon Market Update: Kymera Therapeutics Drops After Q1 Results; Belite Bio Shares Spike Higher

U.S. stocks traded slightly higher toward the end of trading on Tuesday.

Benzinga

Pfizer hopes to submit little-kid vaccine data by early June

Pfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by early June

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer Stock Must Key Support After Mixed Earnings - Chart

Pfizer stock is trying to push higher on earnings but is still vulnerable. Here's the level it has to hold.

The Street

Stock Market Near Session Highs In Afternoon Trade; Job Openings Signal Tight Job Market

The stock market gained as investors await the outcome of the Fed's two-day meeting and digest a report signaling a tight labor market.

Investors Business Daily

Mid-Day Market Update: Dow Jumps 100 Points; Spero Therapeutics Shares Plunge

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Tuesday.

Benzinga

Pfizer Stock Flies Higher Following Q1 Earnings Print: Here's What To Watch For Next

Pfizer, Inc (NYSE: PFE) shot up over 3% on Tuesday after printing its first-quarter earnings before the market open.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Mid-Morning Market Update: Markets Mixed; Dow Drops 50 Points

U.S. stocks traded mixed this morning, with the Dow Jones dropping around 50 points on Tuesday.

Benzinga

Pfizer accused of Covid profiteering as first-quarter sales hit $26bn

Pharma firm criticised over pricing and for keeping monopoly control over vaccine and new Paxlovid pill

The Guardian - UK

Pfizer Fails To Boost Its 2022 Outlook, But Shares Rise

Pfizer stock fell Tuesday after its 2022 outlook missed overly bullish sales estimates. The company also cut its earnings view.

Investors Business Daily

Pfizer Posts Street Beating Q1 Earnings, Revises FY22 Profit Outlook

Pfizer Inc (NYSE:PFE) has reported a Q1 adjusted EPS of $1.62, up 72% Y/Y, well ahead of the consensus of $1.50. The company achieved revenues of $25.66 billion, up 77%, beating the Wall Street estimate of $23.95 billion. Its COVID-19 vaccine, Comirnaty, contributed $13.2 billion in direct sales and alliance revenues. Eliquis…

Benzinga

Dow Jones Falls Ahead Of Fed Meeting; 7 Key Earnings Movers

The Dow Jones Industrial Average fell Tuesday ahead of the Fed's two-day meeting. Mosaic and Pfizer were among seven key earnings movers.

Investors Business Daily

Pfizer: Q1 Earnings Insights

Pfizer (NYSE:PFE) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement. Earnings Pfizer beat estimated earnings by 8.0%, reporting an EPS of $1.62 versus an estimate of $1.5.

Benzinga

Pfizer Tops Q1 Earnings Forecast on Covid Vaccine Sales, Cuts 2022 Profit Outlook

"We continue to supply the world with Comirnaty and we are on track to fulfill our commitment to deliver at least 2 billion doses to low- and middle-income countries," said CEO Albert Bourla.

The Street

Get all your
news in one place.

100’s of premium titles.
One news app.

Birmingham Post

North East deals of the week: contracts, acquisitions and investments

Businesses involved in deals across the region include RSA Insurance, Roman Ltd, Tait Walker and ReViral

StockNews.com

3 High-Quality Stocks to Buy During This Market Selloff

The near-term market outlook remains cloudy. While the S&P 500 is about 3% above its late-February lows, the Nasdaq and Russell 2000 have already undercut these levels. Below are 3 such stocks that investors should consider buying during this market correction: Anthem (ANTM), Pfizer (PFE), and Builders FirstSource (BLDR).

Benzinga

Check Out What Whales Are Doing With PFE

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 16 strange trades.

Benzinga

Moderna Bullish On COVID-19 Vaccine For Younger Kids To Be Ready Next Month: Reuters

Moderna Inc's (NASDAQ:MRNA) chief medical officer said that its COVID-19 vaccine for children under six years old would be ready for review by the FDA panel when it meets in June. "I think the FDA now has all of the core fundamental data they need to be able to begin an application review.…

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Option Trade Profits If Pfizer Stock's Earning Reaction Isn't Crazy

This iron condor trade has the potential to return 32% if the stock price stabilizes and implied volatility drops.

The Street

Stock Market Today - 5/2: Stocks End Higher in Volatile Session With Fed, Earnings, Jobs Data In Focus; 10-Year Yields Hit 3%

Stocks finish higher ahead of another busy week on Wall Street as investors look for relief from the biggest year-to-date decline for the S&P 500 since 1939.

The Street

Pfizer Stock Slides As Data From Covid Antiviral Trial Disappoints Ahead Of Q1 Earnings

“While we are disappointed in the outcome of this particular study, these results do not impact the strong efficacy and safety data we’ve observed in our earlier trial," said CEO Albert Bourla.

The Street

Moderna Seeks Emergency Authorization for Under-6 Covid Vaccine

Children ages 6 months to under 6 years may soon have access to a Covid-19 vaccine that has been submitted to the FDA for emergency use authorization.

Daily Record

Lanarkshire senior nurse urges parents of young children to consider COVID-19 vaccine

The Pfizer vaccine was approved for youngsters in December 2021.

WEKU

She wanted to vaccinate their kids against COVID. He didn't. A judge had to decide

A divorced Pennsylvania couple could not agree on whether to vaccinate their children — and ended up in court. Since the vaccine was approved for kids, cases like these have skyrocketed in the state.

ABC News

Pfizer says its COVID-19 treatment Paxlovid fails to prevent infection of household members

A trial of 3,000 adults finds that the COVID-19 oral antiviral treatment, Paxlovid, is not effective at preventing cross-infection in people living with someone with the virus.

1 … 53 54 55 56

People

Jaimini DesaiJaimini Desai

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.